Bausch Health Companies BHC Allowance for Doubtful Accounts Receivable (Current)
Allowance for Doubtful Accounts Receivable (Current) at other companies
Other financials
Where this comes from
Reported directly by Bausch Health Companies in its filing.
Tagged under the XBRL concept us-gaap:AllowanceForDoubtfulAccountsReceivable.
The official record: Bausch Health Companies’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bausch Health Companies's allowance for doubtful accounts receivable (current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bausch Health Companies's allowance for doubtful accounts receivable (current)?
- Bausch Health Companies (BHC) reported allowance for doubtful accounts receivable (current) of $33M in Q1 2026.
- How has Bausch Health Companies's allowance for doubtful accounts receivable (current) changed year-over-year?
- Bausch Health Companies's allowance for doubtful accounts receivable (current) increased by 13.8% year-over-year, from $29M to $33M.
- What is the long-term trend for Bausch Health Companies's allowance for doubtful accounts receivable (current)?
- Over 4 years (2021 to 2025), Bausch Health Companies's allowance for doubtful accounts receivable (current) has grown at a -3.0% compound annual growth rate (CAGR), from $35M to $31M.
- What does allowance for doubtful accounts receivable (current) mean?
- This is the valuation allowance for current receivables that are considered uncollectible due to disputes, bankruptcy, or other non-payment issues. It serves as a buffer against potential losses from customer defaults. It is a critical indicator of the health of the company's accounts receivable portfolio.